Delivery Order SPE2DB22D1106-SPE2DB25FFHT9
- Not listed
- The Defense Logistics Agency awarded a $35,602.74 delivery order to AmerisourceBergen Drug Corp for the supply of Ozempic (semaglutide) 0.25-0.5 mg/dose pens in 3 mL format. This is a firm fixed-price, competitively awarded contract with no set-aside designation, with a performance location in Conshohocken, Pennsylvania and an ultimate completion date of August 14, 2025. The delivery order was issued on August 13, 2025, as a child contract under AmerisourceBergen's larger pharmaceutical supply...
- The Defense Logistics Agency awarded a delivery order valued at $9,392.34 to AmerisourceBergen Drug Corp for the supply of Ozempic (semaglutide) 0.25–0.5 mg/dose pens in 3 mL formulations. This competitively awarded, firm fixed-price contract was issued on July 23, 2025, with an ultimate completion date of July 24, 2025, and will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. The delivery order carries no set-aside designation, reflecting the open...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for the supply of Ozempic (semaglutide) 0.25-0.5 mg/dose pens in 3 mL vials, with a contract ceiling value of $5,474.77. This non-competitive, firm fixed-price delivery order was awarded on September 10, 2025, with an ultimate completion date of September 11, 2025, and will be performed at the contractor's Corporate Office location in Conshohocken, Pennsylvania. The delivery order represents a discrete...
- The U.S. Defense Logistics Agency (DLA) Medical Supply Chain awarded a delivery order to AmerisourceBergen Drug Corp on August 18, 2025, for the supply of Ozempic (semaglutide) 0.25–0.5 mg/dose pens in 3 mL formulations. This competitively awarded, non-set-aside delivery order carries a ceiling value of $32,930.62 under firm fixed-price terms, with an ultimate completion date of August 19, 2025. The place of performance is AmerisourceBergen's corporate office location in Conshohocken,...
- The Defense Logistics Agency awarded a delivery order valued at $222,547.91 to AmerisourceBergen Drug Corp for the supply of Ozempic (semaglutide) 0.25-0.5 mg/dose pens in 3 mL formulation. This firm fixed-price, non-set-aside delivery order is scheduled for completion by September 11, 2025, and will be fulfilled from AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. The award represents a child contract issued under a larger indefinite delivery contract vehicle....
- The Defense Logistics Agency awarded a delivery order valued at $2,621.17 to AmerisourceBergen Drug Corp for the supply of Ozempic (semaglutide) 0.25-0.5 mg/dose pens in 3ml quantities. This competitively awarded, firm fixed-price delivery order is set to be completed by August 29, 2025, and will be fulfilled from the contractor's facility in Conshohocken, Pennsylvania. The contract represents a child order under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop...
- The Defense Logistics Agency awarded a delivery order valued at $4,361.80 to AmerisourceBergen Drug Corp on August 11, 2025, for the supply of Ozempic (semaglutide) 0.25–0.5 mg/dose pens in 3 mL formulations. This competitive award uses firm fixed pricing with no set-aside designation and is scheduled for completion by August 12, 2025. The order will be fulfilled from AmerisourceBergen's Corporate Office location in Conshohocken, Pennsylvania. This delivery order is issued under...
- The Defense Logistics Agency awarded a delivery order valued at $18,198.96 to AmerisourceBergen Drug Corp for the supply of Ozempic (semaglutide) 0.25-0.5 mg/dose pens in 3mL vials. The contract was competitively awarded with firm fixed pricing and is scheduled for completion by August 13, 2025. AmerisourceBergen will fulfill this order from its corporate office location in Conshohocken, Pennsylvania. This delivery order represents a child contract under AmerisourceBergen's larger Indefinite...
- The Defense Logistics Agency awarded a delivery order valued at $17,574.08 to AmerisourceBergen Drug Corp for the supply of Ozempic 0.25-0.5 mg/dose pens (3ml) on September 9, 2025, with completion targeted for September 10, 2025. This is a firm fixed-price delivery order with no set-aside designation, indicating it was competitively awarded. The pharmaceutical product will be supplied from AmerisourceBergen's facility in Conshohocken, Pennsylvania, where the company maintains its corporate...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 19, 2025, for the supply of Ozempic (semaglutide) 0.25-0.5 mg/dose pens in 3 mL formulations, valued at $30,494.73. This is a firm fixed-price delivery order with an ultimate completion date of August 20, 2025, and represents a non-set-aside competitive award. The product will be delivered to the company's facility in Conshohocken, Pennsylvania. This delivery order is issued under AmerisourceBergen...
- SPE2DB22D1106Indefinite Delivery Contract
- SPE2DB22D1106-SPE2DB25FFHT9Delivery Order
The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for the supply of Ozempic (semaglutide) 0.25-0.5 mg/dose pens in 3 mL vials, with a ceiling value of $4,554.14. This competitively awarded, firm fixed-price delivery order is scheduled for completion by September 10, 2025, and will be fulfilled from AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. The award represents a child contract action under AmerisourceBergen's larger relationship with DLA. This delivery order is issued under AmerisourceBergen's Indefinite Delivery Contract (SPE2DX) with DLA Troop Support Medical, a $999,999,999 global pharmaceutical support vehicle running through December 2026 that enables the company to supply an extensive range of pharmaceutical products and medical supplies to military healthcare systems worldwide. AmerisourceBergen, a major pharmaceutical distributor and critical federal medical procurement vendor, holds a significant portfolio of federal contracts demonstrating its capability to meet diverse healthcare supply requirements across therapeutic domains, including diabetes medications, specialty pharmaceuticals, and medical devices serving the Defense Health Agency, U.S. Coast Guard, and other government healthcare systems.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $4.6k | 9/9/25 |